Differentiated Thyroid Cancer Presenting with Distant Metastases: A Population Analysis Over Two Decades

Abstract

Overall, met-DTC is uncommon. Given the lack of survival improvement observed over the last two decades, novel treatments should be pursued aggressively for this subset of patients.